Tissue engineering

Tissue engineering is a specialized branch of biomedical engineering. It focuses on creating biological substitutes. These substitutes aim to restore, maintain, or improve the function of living tissues. This field can also work to replace entire organs. It combines principles from both the life sciences and engineering. Researchers use cells, engineering materials, and specific biochemical factors to achieve this.

Scientists want to use the natural biology of a system to ensure success. This approach allows for better therapeutic strategies in medicine. The field has grown so much that it is now considered its own discipline. It is no longer just a small part of biomaterials research.

To understand how it works, we can look at the three main approaches. Researchers often use a combination of cells and tissue scaffolds. A scaffold is an engineered extracellular matrix. It acts as a support structure for the cells. Another method uses cells alone. A third method involves using tissue-inducing substances. These are biochemical or physicochemical factors that guide growth.

By combining these elements, scientists can create new, viable tissue. The goal is to produce functional replacement tissue for clinical use. This process relies on understanding the fundamental principles of how tissue grows.

There are many different types of tissues that engineers can target. They might work on bone, cartilage, or muscle. They can also engineer blood vessels, skin, or bladders. Some efforts focus on creating artificial support systems for biochemical functions. For example, an artificial pancreas could help manage blood sugar. A bioartificial liver could assist during acute liver failure.

These devices aim to mimic the natural functions of human organs. Some tissues require very specific mechanical and structural properties. Engineering these properties is a major part of the scientific challenge.

Humanity has attempted to repair the body for thousands of years. As early as 2500 BC, doctors in ancient India used skin grafts. They would move skin from the buttocks to the nose or lips. Ancient Egyptians used linen sutures and honey to help wounds heal. By the 17th century, Robert Hooke discovered the cell. Later, Isaac Newton described the body as a "physiochemical machine."

The modern term emerged in the 1980s. It first appeared in a 1984 publication about an ophthalmic prosthesis. In 1985, Yuan-Cheng Fung proposed joining "tissue" and "engineering." The term was officially adopted in 1987.

Technological leaps have transformed the field in recent decades. In 1960, Wichterle and Lim published work on hydrogels. These materials are now preferred as bio-inks for 3-D bioprinting. In 1984, Charles Hull developed bioprinting using an inkjet printer. A major milestone occurred in 1998 when James Thompson developed human stem cell lines. In 1999, the first laboratory-grown internal organs were transplanted.

By 2003, the University of Missouri created the first bioprinter. This device could print spheroids without needing a scaffold.

Today, 3-D bioprinting is a vital tool in medical engineering. This process uses additive manufacturing for high precision. Researchers use hydrogels because they mimic the natural extracellular matrix. These gels provide the mechanical strength needed for 3-D structures.

Scientists have even printed mini organoids and organs-on-chips. These models help pharmaceutical companies test new drugs. This testing happens before drugs move to animal studies. It provides practical insights into how the human body functions.

We can see successful examples of this science in real patients. A team at the University of Utah printed ears for children. These ears were successfully transplanted into children with developmental defects. Anthony Atala has successfully implanted artificial bladders into human test subjects.

Doris Taylor's lab even constructed a biocompatible rat heart. They used a process called decellularization to strip cells from a heart. They then injected stem cells back into the structure. These breakthroughs show the incredible potential of the field.

Despite these successes, significant challenges still remain. One major hurdle is the need for complex vascularization. This means creating the tiny blood vessels that supply oxygen to tissue. Without blood vessels, large engineered tissues cannot survive. Researchers also work to improve biomechanical stability. They want lab-grown tissues to handle the physical stresses of the body.

Solving these problems will accelerate both basic and clinical research. As technology evolves, our ability to heal the body will continue to grow.